InsiderTrades

Form 4 for TXG 10x Genomics, Inc.

Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001567619-21-021615 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-12-03 2021-12-01 TXG Hindson Benjamin J. See Remarks, Dir M - OptEx $15.14 +41.7K 88.4K +89% +$630.8K
DM 2021-12-03 2021-12-01 TXG Hindson Benjamin J. See Remarks, Dir S - Sale+OE $148.08 -41.7K 56.5K -42% -$6.17M
DM 2021-12-03 2021-12-01 TXG Hindson Benjamin J. See Remarks, Dir M - OptEx $0.00 -41.7K 133.2K -24% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-12-01 M A 3,646 $5.04 50,412 D — —
2 Common Class A Common Stock 2021-12-01 M A 35,232 $11.48 85,644 D — —
3 Common Class A Common Stock 2021-12-01 M A 2,788 $74.58 88,432 D — —
4 Common Class A Common Stock 2021-12-01 S D 5,400 $145.66 83,032 D — — (F2) This transaction was executed in multiple trades at prices ranging from $145.05 to $145.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
5 Common Class A Common Stock 2021-12-01 S D 5,369 $146.53 77,663 D — — (F3) This transaction was executed in multiple trades at prices ranging from $146.095 to $146.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
6 Common Class A Common Stock 2021-12-01 S D 13,561 $147.65 64,102 D — — (F4) This transaction was executed in multiple trades at prices ranging from $147.03 to $147.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
7 Common Class A Common Stock 2021-12-01 S D 200 $155.55 46,766 D — —
8 Common Class A Common Stock 2021-12-01 S D 4,849 $149.46 51,682 D — — (F6) This transaction was executed in multiple trades at prices ranging from $149.065 to $149.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
9 Common Class A Common Stock 2021-12-01 S D 1,816 $150.66 49,866 D — — (F7) This transaction was executed in multiple trades at prices ranging from $150.12 to $151.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
10 Common Class A Common Stock 2021-12-01 S D 2,100 $151.46 47,766 D — — (F8) This transaction was executed in multiple trades at prices ranging from $151.14 to $152.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
11 Common Class A Common Stock 2021-12-01 S D 100 $152.25 47,666 D — —
12 Common Class A Common Stock 2021-12-01 S D 700 $153.91 46,966 D — — (F9) This transaction was executed in multiple trades at prices ranging from $153.665 to $154.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
13 Common Class A Common Stock 2021-12-01 S D 7,571 $148.42 56,531 D — — (F5) This transaction was executed in multiple trades at prices ranging from $148.03 to $148.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
14 Derivative Stock Option (right to buy) 2021-12-01 M D 3,646 $0.00 47,238 D $5.04 · — to 2028-11-02 3,646 Class A Common Stock (F10) This option, originally for 175,000 shares, of which 127,762 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
15 Derivative Stock Option (right to buy) 2021-12-01 M D 35,232 $0.00 33,334 D $11.48 · — to 2029-05-10 35,232 Class A Common Stock (F11) This option, originally for 100,000 shares, of which 66,666 shares have been exercised, vested as to 1/48th of the shares on May 1, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
16 Derivative Stock Option (right to buy) 2021-12-01 M D 2,788 $0.00 133,212 D $74.58 · — to 2030-04-21 2,788 Class A Common Stock (F12) This option, originally for 136,000 shares, of which 2,788 shares have been exercised, vested as to 1/48th of the shares on May 1, 2020 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.